This document is a comprehensive FCC Part 15C test report prepared for Neuspera Medical, Inc. regarding their neurostimulator powering device, identified by FCC ID 2BMNE-WT-002. The report details the testing procedures and results to demonstrate compliance with the Federal Communication Commission's regulations under Part 15, Subpart C.
The report covers a range of tests, including antenna requirements, RF exposure, radiated and conducted spurious emissions, emission bandwidth, maximum output power, channel separation, number of hopping channels, dwell time, and spurious emissions at antenna terminals. The tests were conducted in accordance with ANSI C63.10-2013 and FCC KDB guidelines. The report includes detailed descriptions of the test setups, equipment used, and environmental conditions during testing.
The results indicate that the Neuspera Medical, Inc. device complies with all applicable FCC Part 15C requirements. The report also includes appendices with EUT test setup photographs, external and internal photographs, and the A2LA electrical testing certificate, providing a complete overview of the compliance testing process.
Array
(
[0] => Array
(
[url_sha] => f3c961036d7eff72bc59bf9da5731c32c7c675ac47856d1d173fb04b133b12d6
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8308092
[href_text] => Test Report
[href_description] => Neuspera Medical Inc. WT-002 Neurostimulator Powering Device 2BMNE-WT-002 2BMNEWT002 wt 002
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] =>
[http_filename] => GetApplicationAttachment.html?id=8308092
[http_size] => 1727125
[file_sha256] => 70248e6867f6f398366feaa8c75977e5efd7cf8046b81e323bd4cf4383a6b885
[domain] => document.fccid
)
)
Array
(
[file_sha256] => 70248e6867f6f398366feaa8c75977e5efd7cf8046b81e323bd4cf4383a6b885
[cleanFccId] => 2BMNEWT002
[title] => FCC Part 15C Test Report for Neuspera Medical, Inc.
[description] => Test report for Neuspera Medical, Inc.'s neurostimulator powering device, FCC ID: 2BMNE-WT-002, compliant with FCC Part 15, Subpart C.
[brand_name] => Neuspera Medical, Inc.
[keywords] => ["FCC Part 15C", "2BMNE-WT-002", "Neurostimulator Powering Device", "R2408161-247", "3297.02"]
[intro] =>
This document is a comprehensive FCC Part 15C test report prepared for Neuspera Medical, Inc. regarding their neurostimulator powering device, identified by FCC ID 2BMNE-WT-002. The report details the testing procedures and results to demonstrate compliance with the Federal Communication Commission's regulations under Part 15, Subpart C.
The report covers a range of tests, including antenna requirements, RF exposure, radiated and conducted spurious emissions, emission bandwidth, maximum output power, channel separation, number of hopping channels, dwell time, and spurious emissions at antenna terminals. The tests were conducted in accordance with ANSI C63.10-2013 and FCC KDB guidelines. The report includes detailed descriptions of the test setups, equipment used, and environmental conditions during testing.
The results indicate that the Neuspera Medical, Inc. device complies with all applicable FCC Part 15C requirements. The report also includes appendices with EUT test setup photographs, external and internal photographs, and the A2LA electrical testing certificate, providing a complete overview of the compliance testing process.
)
Array
(
[0] => Array
(
[id] => 8308092
[file_sha256] =>
[applicationId] => r4BN3DPg6fQa6D9VGAMKkg==
[description] => Test Report
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => Test Report
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 1727125
[submissionDate] => 2025-05-20 00:00:00
[dateAvailable] => 2025-05-20 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2BMNE-WT-002
[cleanFccId] => 2BMNEWT002
[exif] => 0
)
)